Cargando…
Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
INTRODUCTION: There is a need to optimise the management of atopic dermatitis (AD), improving the efficacy of treatments and reducing the toxicity associated with them. Although the efficacy of ciclosporine (CsA) in the treatment of AD has been thoroughly documented in the literature, the optimal do...
Autores principales: | Marín-Candón, Alicia, García-García, Irene, Arias, Pedro, Carcas, Antonio J, Díaz-García, Lucía, Feltes Ochoa, Rosa, Hernández Cano, Natalia, Herranz Pinto, Pedro, Jiménez González, María, López -Granados, Eduardo, Martínez-Feito, Ana, Mayor-Ibarguren, Ander, Rosas-Alonso, Rocío, Seco-Meseguer, Enrique, Borobia, Alberto M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335428/ https://www.ncbi.nlm.nih.gov/pubmed/37429687 http://dx.doi.org/10.1136/bmjopen-2023-072350 |
Ejemplares similares
-
Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation
por: Herranz-Pinto, Pedro, et al.
Publicado: (2023) -
Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021) -
Epidemiology of atopic dermatitis in Europe
por: Kowalska-Olędzka, Elżbieta, et al.
Publicado: (2019) -
Management of Atopic Dermatitis: The Role of Tacrolimus
por: Umar, Badar Uddin, et al.
Publicado: (2022) -
Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
por: Narla, Shanthi, et al.
Publicado: (2021)